Cargando…

Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter

Infiltration of leukocytes is a major pathological event in white matter lesion formation in the brain of multiple sclerosis (MS) patients. In grey matter lesions, less infiltration of these cells occur, but microglial activation is present. Thus far, the interaction of β-integrins with extracellula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espitia Pinzon, Nathaly, Stroo, Esther, ‘t Hart, Bert A., Bol, John G. J. M., Drukarch, Benjamin, Bauer, Jan, van Dam, Anne-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069090/ https://www.ncbi.nlm.nih.gov/pubmed/24959868 http://dx.doi.org/10.1371/journal.pone.0100574

Ejemplares similares

Tissue Transglutaminase Appears in Monocytes and Macrophages but Not in Lymphocytes in White Matter Multiple Sclerosis Lesions
por: Chrobok, Navina L, et al.
Publicado: (2019)

Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures
por: Espitia Pinzón, Nathaly, et al.
Publicado: (2017)

Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination
por: Espitia Pinzon, Nathaly, et al.
Publicado: (2017)

Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients
por: Prins, Marloes, et al.
Publicado: (2014)

Tissue Transglutaminase Promotes Early Differentiation of Oligodendrocyte Progenitor Cells
por: Espitia Pinzon, Nathaly, et al.
Publicado: (2019)

Discrepant Effects of Human Interferon-gamma on Clinical and Immunological Disease Parameters in a Novel Marmoset Model for Multiple Sclerosis
por: Jagessar, S. Anwar, et al.
Publicado: (2011)

Interleukin-1β and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis
por: Prins, Marloes, et al.
Publicado: (2013)

Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis
por: Chrobok, Navina L., et al.
Publicado: (2018)

Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis
por: Sestito, Claudia, et al.
Publicado: (2021)

Distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis
por: van Wageningen, Thecla A., et al.
Publicado: (2022)

Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis
por: Chrobok, Navina L., et al.
Publicado: (2018)

Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?
por: Chrobok, Navina L., et al.
Publicado: (2016)

Astrocyte-Derived Tissue Transglutaminase Interacts with Fibronectin: A Role in Astrocyte Adhesion and Migration?
por: van Strien, Miriam E., et al.
Publicado: (2011)

Differential Expression of Tissue Transglutaminase Splice Variants in Peripheral Blood Mononuclear Cells of Primary Progressive Multiple Sclerosis Patients
por: Sestito, Claudia, et al.
Publicado: (2018)

Grey and White Matter Changes across the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Continuum
por: Lillo, Patricia, et al.
Publicado: (2012)

Experimental autoimmune encephalomyelitis in the common marmoset: a translationally relevant model for the cause and course of multiple sclerosis
por: 't Hart, Bert A.
Publicado: (2019)

Monocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1(gfp/gfp) mice
por: Chrobok, Navina L., et al.
Publicado: (2016)

Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?
por: Sestito, Claudia, et al.
Publicado: (2017)

Concurrent analysis of white matter bundles and grey matter networks in the chimpanzee
por: Mars, Rogier B., et al.
Publicado: (2018)

Absence of tissue transglutaminase reduces amyloid‐beta pathology in APP23 mice
por: Wilhelmus, Micha M. M., et al.
Publicado: (2022)

Assessing the Correlation between Grey and White Matter Damage with Motor and Cognitive Impairment in Multiple Sclerosis Patients
por: Sbardella, Emilia, et al.
Publicado: (2013)

Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter
por: Peferoen, Laura A. N., et al.
Publicado: (2015)

Transcriptional profiling of human microglia reveals grey–white matter heterogeneity and multiple sclerosis-associated changes
por: van der Poel, Marlijn, et al.
Publicado: (2019)

Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis
por: Steinbach, Robert, et al.
Publicado: (2021)

Clinical correlates of grey matter pathology in multiple sclerosis
por: Horakova, Dana, et al.
Publicado: (2012)

Meningeal and cortical grey matter pathology in multiple sclerosis
por: Gh Popescu, Bogdan F, et al.
Publicado: (2012)

Progression of regional grey matter atrophy in multiple sclerosis
por: Eshaghi, Arman, et al.
Publicado: (2018)

Grey matter atrophy in patients with benign multiple sclerosis
por: Niiranen, Marja, et al.
Publicado: (2022)

In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model
por: van der Wildt, Berend, et al.
Publicado: (2018)

Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment
por: van Wageningen, Thecla A., et al.
Publicado: (2019)

Regional Grey and White Matter Changes in Heavy Male Smokers
por: Yu, Rongjun, et al.
Publicado: (2011)

Fully automated grey and white matter spinal cord segmentation
por: Prados, Ferran, et al.
Publicado: (2016)

Grey and white matter microstructure is associated with polygenic risk for schizophrenia
por: Stauffer, Eva-Maria, et al.
Publicado: (2021)

A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model
por: ’t Hart, Bert A., et al.
Publicado: (2017)

T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter
por: Kelemen, Peter, et al.
Publicado: (2018)

A resource for detailed 3D mapping of white matter pathways in the marmoset brain
por: Liu, Cirong, et al.
Publicado: (2020)

The Clinical Impact of Cerebellar Grey Matter Pathology in Multiple Sclerosis
por: Damasceno, Alfredo, et al.
Publicado: (2014)

The grey matter correlates of impaired decision-making in multiple sclerosis
por: Muhlert, Nils, et al.
Publicado: (2015)

History of fatigue in multiple sclerosis is associated with grey matter atrophy
por: Palotai, Miklos, et al.
Publicado: (2019)

Patterns of cortical grey matter thickness reduction in multiple sclerosis
por: Fujimori, Juichi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9l12498bjifl2h89c5dqnqvbsi